Stem cell therapy for necrotizing enterocolitis: innovative techniques and procedures for pediatric translational...

Area of Science:

• Neonatal medicine
• Gastroenterology
• Regenerative medicine

Background:

• Necrotizing enterocolitis (NEC) is a critical gastrointestinal condition in premature infants.
• Mesenchymal stem cell (MSC) therapy demonstrates potential in tissue injury protection and has shown efficacy in experimental NEC models.
• Establishing a safe and effective intravenous MSC infusion method for newborns is crucial but underexplored.

Purpose of the Study:

• To describe a novel, safe, and effective technique for systemic Mesenchymal stem cell (MSC) transplantation in newborn rats.
• To address the need for established protocols for intravenous MSC infusion in neonatal settings.

Main Methods:

• Development and application of a non-traumatic intravenous infusion technique for MSCs in a neonatal rat model.
• Systemic transplantation of MSCs via the described method.

Main Results:

• The described technique for systemic MSC transplantation in newborn rats was demonstrated to be safe and effective.
• Successful delivery of MSCs throughout the body was achieved using the novel method.

Conclusions:

• A safe, non-traumatic, and effective technique for systemic Mesenchymal stem cell (MSC) transplantation in newborn rats has been established.
• This method provides a foundation for future studies and potential clinical translation of MSC therapy for neonatal conditions like NEC.